| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 2,3 M € | -25.7% | 3,1 M € | +53.5% | 2,0 M € | +32.9% | 1,5 M € | +48.3% | 1,0 M € | +47.7% | 682,4 k € | +17.5% | 580,8 k € | +14.7% | 506,5 k € | -17.9% | 617,1 k € | -44.7% | 1,1 M € | +16.8% | 954,8 k € | -0.3% | 957,8 k € | +2.7% | 932,6 k € | -0.2% | 934,4 k € | +3.7% | 900,6 k € | -1.2% | 911,5 k € | +10.0% | 828,3 k € | +4.1% | 795,5 k € | |
| EBITDA | 1,4 M € | -19.9% | 1,7 M € | +38.7% | 1,3 M € | +33.0% | 948,2 k € | +89.0% | 501,8 k € | +54.5% | 324,8 k € | +34.0% | 242,4 k € | +14.0% | 212,7 k € | -35.8% | 331,1 k € | -63.1% | 898,2 k € | +11.3% | 807,0 k € | -2.5% | 827,8 k € | +2.9% | 804,3 k € | -1.4% | 815,4 k € | +1.3% | 804,6 k € | -0.7% | 810,0 k € | +7.5% | 753,6 k € | +4.4% | 721,8 k € | |
| Operating profit | 1,1 M € | -32.6% | 1,6 M € | +35.5% | 1,2 M € | +47.2% | 782,1 k € | +124.7% | 348,0 k € | +90.3% | 182,9 k € | +404.6% | 36,3 k € | +294.0% | 9,2 k € | -90.4% | 96,1 k € | -80.2% | 485,7 k € | -8.0% | 528,0 k € | -15.2% | 622,8 k € | +4.7% | 594,8 k € | -2.1% | 607,3 k € | -9.0% | 667,2 k € | -0.0% | 667,4 k € | +11.4% | 599,4 k € | -0.4% | 601,8 k € | |
| Profit/loss | 799,7 k € | -30.6% | 1,2 M € | +37.7% | 836,9 k € | +49.5% | 559,7 k € | +103.1% | 275,5 k € | +59.3% | 172,9 k € | +536.9% | 27,2 k € | -42.4% | 47,1 k € | +112.8% | -368,3 k € | -26.8% | -290,4 k € | -167.0% | 433,8 k € | -30.7% | 625,7 k € | +20.3% | 520,1 k € | +0.1% | 519,6 k € | +4.1% | 499,1 k € | -9.5% | 551,7 k € | +43.9% | 383,5 k € | -15.2% | 452,0 k € | |
| Equity | 3,9 M € | +25.5% | 3,1 M € | +57.9% | 2,0 M € | -13.1% | 2,3 M € | +32.4% | 1,7 M € | +19.0% | 1,5 M € | +13.5% | 1,3 M € | -71.8% | 4,5 M € | +1.0% | 4,5 M € | -7.6% | 4,9 M € | -5.6% | 5,2 M € | +1.4% | 5,1 M € | +14.0% | 4,5 M € | +13.2% | 3,9 M € | +15.2% | 3,4 M € | +17.1% | 2,9 M € | +23.3% | 2,4 M € | +19.4% | 2,0 M € | |
| Total assets | 4,9 M € | +23.3% | 3,9 M € | +16.8% | 3,4 M € | -41.3% | 5,8 M € | +11.9% | 5,1 M € | -4.4% | 5,4 M € | +2.7% | 5,2 M € | +0.5% | 5,2 M € | -2.1% | 5,3 M € | -3.8% | 5,5 M € | -9.3% | 6,1 M € | +10.1% | 5,5 M € | +11.1% | 5,0 M € | +8.4% | 4,6 M € | +15.4% | 4,0 M € | +8.9% | 3,7 M € | +18.1% | 3,1 M € | +18.3% | 2,6 M € | |
| Cash | 486,5 k € | -82.5% | 2,8 M € | +23.2% | 2,3 M € | +70.1% | 1,3 M € | +88.3% | 705,8 k € | -48.3% | 1,4 M € | +37.0% | 996,4 k € | -18.6% | 1,2 M € | +6.9% | 1,1 M € | +33.0% | 861,3 k € | -35.2% | 1,3 M € | +27.0% | 1,0 M € | +9.8% | 953,3 k € | +32.9% | 717,6 k € | -63.1% | 1,9 M € | +18.2% | 1,6 M € | +204.4% | 539,7 k € | -5.5% | 571,2 k € | |
| Debts | 628,1 k € | -16.9% | 756,2 k € | -45.6% | 1,4 M € | -59.9% | 3,5 M € | +1.6% | 3,4 M € | -13.0% | 3,9 M € | -0.8% | 3,9 M € | +493.1% | 665,8 k € | -19.2% | 824,1 k € | +24.3% | 663,2 k € | -29.2% | 936,5 k € | +109.1% | 447,9 k € | -13.7% | 519,3 k € | -20.5% | 653,2 k € | +16.3% | 561,8 k € | -23.8% | 737,4 k € | +1.2% | 728,4 k € | +15.1% | 632,5 k € | |
| Staff | 19,1 | 17,5 | 17,1 | 14,4 | 13,4 | 9,5 | 6,2 | 7,6 | 6,6 | 4,7 | 4,2 | 4,6 | 4,1 | 3,9 | 3,4 | 3,4 | 3,3 | 3 | ||||||||||||||||||
Private limited company · Genk · incorporated on 20/10/1998 · 19,1 ETP
Private limited company profitable and well capitalised. Cash position declining (-82.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
RADIOLOGIE DR. HANS JASPERS is a Private limited company incorporated in 1998. Its main activity is: Specialist medical practice activities. Its registered office is in Genk. It employs on average 19,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette